Slides

Data-driven identification of health conditions associated with incident Alzheimer’s disease dementia risk: a 15 years follow-up cohort from electronic health records in France and the United Kingdom”

Thomas Nedelec

Paris Brain Institute

Thomas_Nedelec

“Dissecting the causal question underlying the association between cancer and dementia”

L. Paloma Rojas-Saunero

Erasmus MC

L. Paloma Rojas-Saunero

“Using State Space Models for Longitudinal Neuropsychological Outcomes” 

Zach Baucom

Boston University School of Public Health

Zach Baucom MELODEM

“Methodological features and FDA’s regulatory guidance on aducanumab and Alzheimer drug development” 

Lon Schneider

University of Southern California

Lon Schneider MELODEM

“The Challenge of Health Equity in Clinical Research: Towards a Quantifiable Science of Inclusion.” 

Jonathan Jackson

Harvard Medical School/Massachusetts General Hospital

The Challenge of Health Equity in Clinical Research_ JJackson_2020

“Towards Real-World Data for Dementia Studies: Use of machine-learning to improve metrics”

Deborah Blacker & Sudha Seshadri

Harvard Medical School/Massachusetts General Hospital

Towards Real-World Data for Dementia Studies_SDas_DBlacker_2020

“Implications of covid for dementia researchers”

Bryan James

Rush Alzheimer’s Disease Center

The intersection of COVID-19 and dementia: a double hit for older adults_BJames_2020